新規登録 | ログイン | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jyuh Plutzky [10 articles]

最近 jyuh さんのライブラリに追加された論文の中から 著者が Plutzky. であるものをリストアップしています. You can also see everyone's Plutzky.
  • Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
    The Lancet, Vol. 371, No. 9626., pp. 1800-1809.
    by Theodore Mazzone, Alan Chait, Jorge Plutzky
    posted to cv dm by jyuh on 2008-06-02 03:42:57 as **
  • PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
    J Intern Med, Vol. 262, No. 2. (August 2007), pp. 184-198.
    posted to no-tag by jyuh on 2008-02-28 02:42:44 as **
  • Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
    Circulation, Vol. 115, No. 4. (30 January 2007), pp. 518-533.
    by JD Brown, J Plutzky
    posted to no-tag by jyuh on 2008-02-28 02:40:35 as **
  • International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
    Pharmacol Rev, Vol. 58, No. 4. (1 December 2006), pp. 726-741.
    by Liliane Michalik, Johan Auwerx, Joel P Berger, Krishna V Chatterjee, Christopher K Glass, Frank J Gonzalez, Paul A Grimaldi, Takashi Kadowaki, Mitchell A Lazar, Stephen O'Rahilly, Colin N Palmer, Jorge Plutzky, Janardan K Reddy, Bruce M Spiegelman, Bart Staels, Walter Wahli
    posted to no-tag by jyuh on 2008-02-28 00:23:42 as **
  • PPARalpha in atherosclerosis and inflammation.
    Biochim Biophys Acta, Vol. 1771, No. 8. (August 2007), pp. 972-982.
    posted to no-tag by jyuh on 2008-02-27 16:35:14 as **
  • Cardiovascular Disease, Chronic Kidney Disease, and Type 2 Diabetes Mellitus: Proceeding with Caution at a Dangerous Intersection
    J Am Soc Nephrol, Vol. 19, No. 1. (1 January 2008), pp. 4-7.
    by Takeshi Kanda, Shu Wakino, Koichi Hayashi, Jorge Plutzky
    posted to no-tag by jyuh on 2008-01-08 04:07:07 as **
  • The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).
    Circulation, Vol. 114, No. 25. (19 December 2006), pp. 2850-2870.
    by VJ Dzau, EM Antman, HR Black, DL Hayes, JE Manson, J Plutzky, JJ Popma, W Stevenson
    posted to no-tag by jyuh on 2007-12-17 02:49:19 as **
  • The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.
    Circulation, Vol. 114, No. 25. (19 December 2006), pp. 2871-2891.
    by VJ Dzau, EM Antman, HR Black, DL Hayes, JE Manson, J Plutzky, JJ Popma, W Stevenson
    posted to no-tag by jyuh on 2007-12-17 02:48:56 as **
  • Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
    Am J Cardiol, Vol. 99, No. 4A. (19 February 2007)
    by P Libby, J Plutzky
    posted to no-tag by jyuh on 2007-09-04 05:43:26 as **
  • Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Circulation, Vol. 115, No. 1. (2 January 2007), pp. 114-126.
    by JB Buse, HN Ginsberg, GL Bakris, NG Clark, F Costa, R Eckel, V Fonseca, HC Gerstein, S Grundy, RW Nesto, MP Pignone, J Plutzky, D Porte, R Redberg, KF Stitzel, NJ Stone, ,
    posted to no-tag by jyuh on 2007-08-21 04:13:21 as **
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/user/jyuh/author/Plutzky

    RIS BibTeX